← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Primetime Life Sciences, Llc
Germantown, MD
$5,783,007
Total funding
2
Grants
Funding over time
peak $1M · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,783,007 · 2
By mechanism
R44$5,783,007 · 2
Investigators at Primetime Life Sciences, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of PTLS-209 for treatment for giardiasis$1,000,000
R44 · FY2025 · AI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$935,028
R44 · FY2021 · MH
Development of PTLS-209 for treatment for giardiasis$915,901
R44 · FY2024 · AI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$840,580
R44 · FY2020 · MH
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$807,479
R44 · FY2019 · MH
Development of PTLS-209 for treatment for giardiasis$633,977
R44 · FY2023 · AI
Development of an adenosine A1 receptors agonist, MRS5474 for the treatment of chronic depression$350,042
R44 · FY2018 · MH
Development of PTLS-209 for treatment for giardiasis$300,000
R44 · FY2022 · AI